Data are presented as number or hazard ratio (95% CI).
*In model 1, the following confounders were adjusted: age, sex, race and ethnicity, educational status, physical activity, smoking status, body mass index, duration of diabetes, hypertension, hypercholesterolemia, previous history of myocardial infarction, previous history of stroke/transient ischemic attack, previous history of chronic heart failure, glycated hemoglobin levels, estimated glomerular filtration rate levels, glycemic treatment assignment (insulin sensitizing or insulin providing), and cardiac treatment assignment (early revascularization or medical therapy). †In model 2, the following confounders were adjusted: age, sex, race and ethnicity, educational status, physical activity, smoking status, body mass index, duration of diabetes, hypertension, hypercholesterolemia, previous history of myocardial infarction, previous history of stroke/transient ischemic attack, previous history of chronic heart failure, glycated hemoglobin levels, estimated glomerular filtration rate levels, use of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, use of beta blockers, use of
